|
| Status |
Public on Sep 12, 2017 |
| Title |
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
MYCN-high and MYCN-low neuroblastoma cells differ in their responses to Doxorubicin treatment. To explain this difference we compared the global trancriptomes of MYCN-high and MYCN-low cells before, during and after treatment.
|
| |
|
| Overall design |
MYCN-high cells without doxycyline and MYCN-low cells with doxycycline were treated with 0.1µg/ml Doxorubicin. Transcriptome was measured for the following time points: in untreated cells, in cells which were treated with Doxorubicin for 72 hours, and in cells collected three, eight and fourteen days after Doxorubin washout. Experiment was performed in biological duplicate.
|
| |
|
| Contributor(s) |
Ryl T |
| Citation(s) |
28843484 |
| |
| Submission date |
Apr 27, 2017 |
| Last update date |
May 15, 2019 |
| Contact name |
Tatsiana Ryl |
| Organization name |
German Cancer Research Center
|
| Department |
Theoretical Systems Biology
|
| Street address |
Im Neuenheimer Feld 280
|
| City |
Heidelberg |
| ZIP/Postal code |
69120 |
| Country |
Germany |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (19)
|
|
| Relations |
| BioProject |
PRJNA384515 |
| SRA |
SRP105329 |
Less...
More...